NCT03398330View on ClinicalTrials.gov

OTR Tablet 40 mg Fed-state Bioequivalence Study

PHASE1CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

March 16, 2017

Primary Completion Date

September 5, 2017

Study Completion Date

November 6, 2017

Conditions
Chronic Pain
Interventions
DRUG

Oxycodone Tamper Resistant

Orally taking Oxycodone Tamper Resistant 40mg in fed state

DRUG

OxyContin®

Orally taking OXYCONTIN® 40mg in fed state

Trial Locations (1)

410008

Xiangya Hospital of Central South University, Changsha

All Listed Sponsors
lead

Mundipharma (China) Pharmaceutical Co. Ltd

INDUSTRY

NCT03398330 - OTR Tablet 40 mg Fed-state Bioequivalence Study | Biotech Hunter | Biotech Hunter